See the Full Picture.
Published loading...Updated

Biden Officials Knew About, Downplayed Risks From COVID-19 Vaccines, Senate Report Claims

  • On May 22, 2025, the FDA instructed Pfizer and Moderna to revise their COVID-19 vaccine labeling to include warnings regarding an uncommon risk of heart inflammation primarily affecting males aged 16 to 25 in the United States.
  • This action followed new safety data and a 2023 study showing the highest myocarditis risk is for males aged 16 to 25 after mRNA COVID vaccines.
  • The updated warnings specify 38 cases of myocarditis or pericarditis per million doses in this group, with most cases improving over time, though long-term effects remain unknown.
  • FDA spokesperson Andrew Nixon highlighted the agency’s dedication to full transparency, while Pfizer and Moderna are given a month-long period to respond and have yet to release any public comments.
  • This development followed a Senate Homeland Security Committee report alleging the Biden administration downplayed myocarditis risks to avoid vaccine hesitancy, prompting ongoing studies into long-term vaccine effects.
Insights by Ground AI
Does this summary seem wrong?

63 Articles

All
Left
3
Center
7
Right
37
The Norfolk Daily NewsThe Norfolk Daily News
+12 Reposted by 12 other sources
Center

FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines

Key Takeaways

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 79% of the sources lean Right
79% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The National Desk broke the news in on Wednesday, May 21, 2025.
Sources are mostly out of (0)